Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
HERON THERAPEUTICS, INC. /DE/ | Director | Common Stock | 69.2K | $149K | $2.15 | Jan 19, 2024 | Direct |
HERON THERAPEUTICS, INC. /DE/ | Director | Stock Option (Right to Buy) | 83.7K | Jan 19, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
HRTX | HERON THERAPEUTICS, INC. /DE/ | Jan 19, 2024 | 2 | $0 | 4 | Jan 19, 2024 | Director |
HRTX | HERON THERAPEUTICS, INC. /DE/ | Dec 16, 2022 | 2 | $0 | 4 | Dec 20, 2022 | Director |
HRTX | HERON THERAPEUTICS, INC. /DE/ | Dec 22, 2021 | 2 | $0 | 4 | Dec 23, 2021 | Director |
HRTX | HERON THERAPEUTICS, INC. /DE/ | Sep 20, 2021 | 0 | $0 | 3 | Sep 29, 2021 | Director |